Holen Sie sich die Stockscreener-App
7.02
0.43%
0.03
Schlusskurs vom Vortag:
$6.99
Offen:
$7.05
24-Stunden-Volumen:
206.55K
Relative Volume:
0.44
Marktkapitalisierung:
$281.53M
Einnahmen:
$324.01M
Nettoeinkommen (Verlust:
$-192.37M
KGV:
43.87
EPS:
0.16
Netto-Cashflow:
$-23.46M
1W Leistung:
+4.15%
1M Leistung:
+4.31%
6M Leistung:
+13.78%
1J Leistung:
+4.00%
1-Tages-Spanne:
$6.98
$7.12
1-Wochen-Bereich:
$6.71
$7.12
52-Wochen-Spanne:
$5.26
$8.25
Angiodynamic Inc Stock (ANGO) Company Profile
Firmenname
Angiodynamic Inc
Sektor
Telefon
(518) 798-1215
Adresse
14 PLAZA DRIVE, LATHAM
Vergleichen Sie ANGO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ANGO
Angiodynamic Inc
|
7.02 | 281.53M | 324.01M | -192.37M | -23.46M | 0.16 |
|
ISRG
Intuitive Surgical Inc
|
538.55 | 192.83B | 7.87B | 2.24B | 586.00M | 4.25 |
|
BDX
Becton Dickinson Co
|
221.98 | 64.77B | 20.18B | 1.73B | 3.07B | 5.51 |
|
ALC
Alcon Inc
|
88.23 | 43.75B | 9.76B | 1.16B | 665.00M | 0.72 |
|
RMD
Resmed Inc
|
249.33 | 36.84B | 4.81B | 1.11B | 1.35B | 6.16 |
|
WST
West Pharmaceutical Services Inc
|
323.32 | 23.33B | 2.88B | 499.60M | 321.60M | 7.41 |
Angiodynamic Inc Stock (ANGO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-04-05 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2023-09-25 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-04-17 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2021-10-15 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2021-08-20 | Eingeleitet | Oppenheimer | Perform |
| 2020-11-25 | Hochstufung | Raymond James | Mkt Perform → Strong Buy |
| 2020-04-08 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-04-01 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2018-04-03 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2018-01-05 | Herabstufung | Craig Hallum | Buy → Hold |
| 2017-04-07 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2017-03-30 | Herabstufung | KeyBanc Capital Mkts | Overweight → Sector Weight |
| 2017-02-08 | Eingeleitet | Barclays | Equal Weight |
| 2016-11-04 | Eingeleitet | Cantor Fitzgerald | Buy |
| 2016-04-08 | Fortgesetzt | Piper Jaffray | Neutral |
| 2016-01-08 | Bestätigt | Canaccord Genuity | Buy |
| 2015-11-10 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2015-07-24 | Eingeleitet | KeyBanc Capital Mkts | Overweight |
| 2014-06-19 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2012-10-09 | Bestätigt | Canaccord Genuity | Hold |
| 2012-06-25 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2011-07-15 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2011-07-15 | Hochstufung | Stifel Nicolaus | Hold → Buy |
| 2011-06-14 | Herabstufung | Wedbush | Neutral → Underperform |
| 2010-09-08 | Bestätigt | Wedbush | Neutral |
Alle ansehen
Angiodynamic Inc Aktie (ANGO) Neueste Nachrichten
Segall Bryant & Hamill LLC Has $7.09 Million Stake in AngioDynamics, Inc. (NASDAQ:ANGO) - MarketBeat
NeuroOne Medical Technologies (NASDAQ:NMTC) and AngioDynamics (NASDAQ:ANGO) Critical Review - Defense World
Royce & Associates LP Has $7.67 Million Holdings in AngioDynamics, Inc. (NASDAQ:ANGO) - MarketBeat
AngioDynamics, Inc. (NASDAQ:ANGO) Short Interest Update - MarketBeat
Wealth Enhancement Advisory Services LLC Buys New Shares in AngioDynamics, Inc. (NASDAQ:ANGO) - Defense World
AngioDynamics (NASDAQ:ANGO) Share Price Crosses Above 200 Day Moving Average – What’s Next? - Defense World
AngioDynamics Stock Plunges 13.8% in Three Months: What's Next? - MSN
AngioDynamics staying in Queensbury after all. Leaders cite changed business model. - The Post Star
SG Americas Securities LLC Invests $103,000 in AngioDynamics, Inc. (NASDAQ:ANGO) - Defense World
Short Interest in AngioDynamics, Inc. (NASDAQ:ANGO) Rises By 31.0% - MarketBeat
Cwm LLC Raises Stock Position in AngioDynamics, Inc. (NASDAQ:ANGO) - Defense World
Here's Why You Should Add AngioDynamics Stock to Your Portfolio - MSN
AngioDynamics (NASDAQ:ANGO) Stock Price Passes Above 200-Day Moving Average – Should You Sell? - Defense World
AngioDynamics’ NanoKnife System gains CPT codes for prostate and liver treatments - Medical Device Network
AngioDynamics Announces American Medical Association’s CPT® Editorial Panel Grants Category I CPT® for Irreversible Electroporation (IRE) in Prostate and Liver - StockTitan
Angiodynamic Inc (ANGO)’s stock decline to 6.33 per share - US Post News
AngioDynamics Xcela Port Catheter Problems Caused Sepsis Infection, Lawsuit Claims - AboutLawsuits.com
Its Stock Has Paid Off Big Time For Angiodynamic Inc - SETE News
Angel One Profits Jump 39% Thanks To Trading Boom - Finimize
A Guide To The Risks Of Investing In Angiodynamic Inc (ANGO) - Knox Daily
AngioDynamics, Inc. (NASDAQ:ANGO) Sees Significant Decrease in Short Interest - MarketBeat
Insider Buying: Nighan Warren JR, Angiodynamic Inc [ANGO] SVP Quality and Regulatory invested 768 shares - Knox Daily
Study Begins For AngioDynamics' AlphaVac F18⁸⁵ System - MPO-mag
Perrigo Company plc [PRGO] Records 50-Day SMA of $27.19 - Knox Daily
Marshall Wace LLP Sells 218,500 Shares of AngioDynamics, Inc. (NASDAQ:ANGO) - MarketBeat
AQR Capital Management LLC Sells 95,983 Shares of AngioDynamics, Inc. (NASDAQ:ANGO) - MarketBeat
Mackenzie Financial Corp Acquires Shares of 13,270 AngioDynamics, Inc. (NASDAQ:ANGO) - Defense World
3 Stocks Insiders Are Buying Heavily in October and Why - Investing.com
The Angiodynamic Inc (ANGO) had a good session last reading, didn’t it? - US Post News
Dimensional Fund Advisors LP Sells 242,478 Shares of AngioDynamics, Inc. (NASDAQ:ANGO) - MarketBeat
James C. Clemmer Buys 20,000 Shares of AngioDynamics, Inc. (NASDAQ:ANGO) Stock - MarketBeat
AngioDynamics CFO acquires $9.96k in company stock - Investing.com
AngioDynamics, Inc. (NASDAQ:ANGO) Shares Sold by Williams & Novak LLC - Defense World
Check out these key findings about Angiodynamic Inc (ANGO) - SETE News
Analysts review Angiodynamic Inc’s rating - Knox Daily
Deeper Dive: Understanding Angiodynamic Inc (ANGO) Through its Various Ratios - The Dwinnex
Annaly Capital Management Inc [NLY] Insider Finkelstein David L sells 50,000 Shares - Knox Daily
Millennium Management LLC Raises Position in AngioDynamics, Inc. (NASDAQ:ANGO) - MarketBeat
Insider Buying: President and CEO James Clemmer Acquires Shares of AngioDynamics Inc (ANGO) - GuruFocus.com
Angiodynamic Inc (ANGO) Stock: Navigating Drops and Gains - The InvestChronicle
AngioDynamics slides after Q1 revenue miss - MSN
Angiodynamic Inc [ANGO] Shares Fall -16.73 % on Thursday - Knox Daily
AngioDynamics, Inc. (NASDAQ:ANGO) Misses Revenue Estimates - FXDailyReport.com
AngioDynamics Stock Up on Q1 Earnings Beat, Y/Y Pro-Forma Sales Rise - Yahoo Finance
Prepare Yourself for Liftoff: Angiodynamic Inc (ANGO) - SETE News
AngioDynamics, Inc. (NASDAQ:ANGO) Q1 2025 Earnings Call Transcript - Insider Monkey
AngioDynamics, Inc. (NASDAQ:ANGO): Are Analysts Optimistic? - Simply Wall St
AngioDynamics Sees Growth Amidst Challenges in Fiscal 2025 - Yahoo Finance
Market Momentum: Angiodynamic Inc (ANGO) Registers a -16.73 Decrease, Closing at 6.37 - The Dwinnex
NVIDIA Corp [NASDAQ: NVDA] Sees Increase in Stock Value - Knox Daily
Director MILLER JAMES H sale 1,006 shares of Crown Holdings, Inc. [CCK] - Knox Daily
Finanzdaten der Angiodynamic Inc-Aktie (ANGO)
Umsatz
Nettogewinn
Free Cashflow
ENV
Angiodynamic Inc-Aktie (ANGO) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Nighan Warren JR | SVP Quality and Regulatory |
Oct 10 '24 |
Buy |
6.08 |
100 |
608 |
45,877 |
| Trowbridge Stephen A | EVP and CFO |
Oct 08 '24 |
Buy |
5.86 |
1,700 |
9,962 |
172,711 |
| Clemmer James C | President and CEO |
Oct 07 '24 |
Buy |
6.03 |
20,000 |
120,600 |
681,582 |
| Piccinini Laura | SVP International |
Jul 17 '24 |
Option Exercise |
0.00 |
4,439 |
0 |
42,491 |
| Clemmer James C | President and CEO |
Jul 17 '24 |
Option Exercise |
0.00 |
56,279 |
0 |
690,312 |
| Nighan Warren JR | SVP Quality and Regulatory |
Jul 17 '24 |
Option Exercise |
0.00 |
5,677 |
0 |
46,675 |
| Campbell Chad Thomas | SVP/GM, Vascular Access |
Jul 17 '24 |
Option Exercise |
0.00 |
6,600 |
0 |
70,187 |
| Trowbridge Stephen A | EVP and CFO |
Jul 17 '24 |
Option Exercise |
0.00 |
11,142 |
0 |
177,612 |
| Clemmer James C | President and CEO |
Apr 08 '24 |
Buy |
6.70 |
10,000 |
67,000 |
539,066 |
0.14%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):